9 top medical experts on AB Variant Tay-Sachs Disease across 2 countries. This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. AB Variant Tay-Sachs Disease: A progressive neurodegenerative disorder that begins with muscle weakness, then progresses to startle reaction, retardation and seizures. It is characterized by the accumulation of G(M2) ganglioside in neurons that is caused by a lack of G(M2) activator protein function. The AB variant designation refers to the increase of both hexosaminidase A and hexosaminidase B in tissues that lack of G(M2) activator protein.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): GM2 Gangliosidoses (357).
  4. Clinical Trials ClinicalTrials.gov : at least 2 including 1 Completed, 1 Recruiting
  5. Synonyms: GM2 Protein Activator Deficiency Disease,  AB Variant Gangliosidosis GM2,  Type AB Gangliosidosis GM2


  

        

                    


    Computing Expert Listing ...

);